{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:04:20Z","timestamp":1772773460221,"version":"3.50.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["980905"],"award-info":[{"award-number":["980905"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>COVID-19-associated mucormycosis (CAM) has emerged as a serious complication of COVID-19, exacerbated by the use of immunosuppressive treatments. This study aims to assess the clinical outcomes and identify predictors of mortality in adult patients with CAM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study was conducted at a major referral center in Mashhad, Iran, from the start of the COVID-19 pandemic until the end of its fifth wave in Iran.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 81 patients studied, 55.6% were male, with a median age of 60.0 years. Diabetes mellitus was the most common comorbidity, present in 76.5% of patients. Corticosteroids were used in 90.1% of cases. One-month survival was 61.7%, decreasing to 51.9% at three months and stabilizing at 50.6% at six and twelve months. CRP levels were associated with increased mortality (P-value = .001), while longer antifungal treatment duration was linked to reduced mortality (P-value &amp;lt; .001). Moreover, palatal necrosis (HR: 2.12) and the use of posaconazole (HR: 0.16) were significantly associated with the risk of mortality. While the former was a risk factor, the latter reduced the mortality rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study contributes to the growing body of evidence on the clinical and epidemiological characteristics of CAM, highlighting the need for early diagnosis, risk factor identification, and prompt, prolonged treatment to enhance patient outcomes. Elevated CRP was identified as a predictor of mortality in CAM. Future research should aim to refine risk stratification methods and optimize therapeutic protocols to address the high mortality rates associated with this severe condition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf674","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:11:31Z","timestamp":1761829891000},"source":"Crossref","is-referenced-by-count":1,"title":["COVID-19-Associated Mucormycosis: Identifying Mortality Predictors in a Retrospective Cohort Study"],"prefix":"10.1093","volume":"12","author":[{"given":"Zahra","family":"Ghavami","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Mashhad University of Medical Sciences , Mashhad ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboubeh","family":"Haddad","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Mashhad University of Medical Sciences , Mashhad ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0766-4286","authenticated-orcid":false,"given":"Fereshte","family":"Sheybani","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Mashhad University of Medical Sciences , Mashhad ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9311-081X","authenticated-orcid":false,"given":"Matin","family":"Shirazinia","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Mashhad University of Medical Sciences , Mashhad ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maliheh","family":"Dadgar Moghadam","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Faculty of Medicine, Mashhad University of Medical Sciences , Mashhad ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"2025112007565563500_ofaf674-B1","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.3390\/v14122785","article-title":"The role of bacterial and fungal superinfection in critical COVID-19","volume":"14","author":"Seitz","year":"2022","journal-title":"Viruses"},{"key":"2025112007565563500_ofaf674-B2","first-page":"e10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"Mehta","year":"2020","journal-title":"Cureus"},{"key":"2025112007565563500_ofaf674-B3","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2025112007565563500_ofaf674-B4","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.15190\/d.2021.5","article-title":"High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections","volume":"9","author":"Bhatt","year":"2021","journal-title":"Discoveries"},{"key":"2025112007565563500_ofaf674-B5","doi-asserted-by":"crossref","first-page":"110613","DOI":"10.1016\/j.mehy.2021.110613","article-title":"Does COVID 19 generate a milieu for propagation of mucormycosis?","volume":"152","author":"Pandiar","year":"2021","journal-title":"Med Hypotheses"},{"key":"2025112007565563500_ofaf674-B6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jiph.2022.10.011","article-title":"Mucormycosis an added burden to COVID-19 patients: an in-depth systematic review","volume":"15","author":"Shah","year":"2022","journal-title":"J Infect Public Health"},{"key":"2025112007565563500_ofaf674-B7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12070-021-02807-2","article-title":"Epidemiology, clinical features and management of rhino orbital mucormycosis in post COVID 19 patients","volume":"74","author":"Desai","year":"2022","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"2025112007565563500_ofaf674-B8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3390\/diagnostics14040429","article-title":"COVID-19-associated rhino-orbital mucormycosis: histological and electron microscopy characteristics","volume":"14","author":"Jeican","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"2025112007565563500_ofaf674-B9","doi-asserted-by":"crossref","first-page":"101010","DOI":"10.1016\/j.lanepe.2024.101010","article-title":"Epidemiology and prognostic factors of mucormycosis in France (2012\u20132022): a cross-sectional study nested in a prospective surveillance programme","volume":"45","author":"Gouzien","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2025112007565563500_ofaf674-B10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cmi.2023.03.008","article-title":"COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases","volume":"29","author":"\u00d6zbek","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2025112007565563500_ofaf674-B11","doi-asserted-by":"crossref","first-page":"888452","DOI":"10.3389\/fmicb.2022.888452","article-title":"Fungal infection in co-infected patients with COVID-19: an overview of case reports\/case series and systematic review","volume":"13","author":"Seyedjavadi","year":"2022","journal-title":"Front Microbiol"},{"key":"2025112007565563500_ofaf674-B12","first-page":"504","article-title":"Mucormycosis in COVID-19: a systematic review of literature","volume":"29","author":"Nagalli","year":"2021","journal-title":"Infez Med"},{"key":"2025112007565563500_ofaf674-B13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/ijp.ijp_839_21","article-title":"Rhino-orbital-cerebral-mucormycosis in COVID-19: a systematic review","volume":"53","author":"Bhattacharyya","year":"2021","journal-title":"Indian J Pharmacol"},{"key":"2025112007565563500_ofaf674-B14","first-page":"2467","article-title":"Mucormycosis, new causative agents, and new susceptible populations: review of cases in a tertiary care hospital in Iran (2007\u20132021)","volume":"52","author":"Darazam","year":"2023","journal-title":"Iran J Public Health"},{"key":"2025112007565563500_ofaf674-B15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/IOP.0000000000002256","article-title":"Retrobulbar injection of amphotericin B in patients with COVID-19 associated orbital mucormycosis: a systematic review","volume":"38","author":"Sharifi","year":"2022","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2025112007565563500_ofaf674-B16","doi-asserted-by":"crossref","first-page":"e8154","DOI":"10.1002\/ccr3.8154","article-title":"Radiological features of COVID-19-associated mucormycosis: a report of 36 cases along with a literature review","volume":"11","author":"Omranzadeh","year":"2023","journal-title":"Clin Case Rep"},{"key":"2025112007565563500_ofaf674-B17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.61186\/wjps.12.3.64","article-title":"Evaluation of clinical manifestations, pattern of involvement, and surgical outcomes in patients with post COVID-19 head and neck mucormycosis infection among patients admitted to Namazi Hospital, shiraz, Iran (2021\u20132022)","volume":"12","author":"Nahaei","year":"2023","journal-title":"World J Plast Surg"},{"key":"2025112007565563500_ofaf674-B18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11282-022-00650-x","article-title":"Post-COVID mucormycosis osteomyelitis and its imaging manifestations in the North of Iran: case series","volume":"40","author":"Motevasseli","year":"2024","journal-title":"Oral Radiol"},{"key":"2025112007565563500_ofaf674-B19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12070-022-03315-7","article-title":"Post COVID-19 mucormycosis-the horizon","volume":"75","author":"Reddy","year":"2023","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"2025112007565563500_ofaf674-B20","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.4103\/jfmpc.jfmpc_1934_21","article-title":"A systematic review of mucormycosis cases in COVID-19: is it an unholy trilogy of COVID-19, diabetes mellitus, and corticosteroids?","volume":"11","author":"Kumar","year":"2022","journal-title":"J Family Med Prim Care"},{"key":"2025112007565563500_ofaf674-B21","doi-asserted-by":"crossref","first-page":"e0271333","DOI":"10.1371\/journal.pone.0271333","article-title":"COVID-19-associated fungal infections in Iran: a systematic review","volume":"17","author":"Nazari","year":"2022","journal-title":"PLoS One"},{"key":"2025112007565563500_ofaf674-B22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/10668969221099626","article-title":"Histopathological study of mucormycosis in post COVID-19 patients and factors affecting it in a tertiary care hospital","volume":"31","author":"Sree Lakshmi","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"2025112007565563500_ofaf674-B23","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"2025112007565563500_ofaf674-B24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, uncontrolled diabetes and corticosteroids\u2014an unholy Trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis","volume":"20","author":"Moorthy","year":"2021","journal-title":"J Maxillofac Oral Surg"},{"key":"2025112007565563500_ofaf674-B25","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.4103\/ijo.IJO_1316_21","article-title":"Mucormycosis in COVID-19 patients","volume":"69","author":"Sundaram","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"2025112007565563500_ofaf674-B26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2025112007565563500_ofaf674-B27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/sja.sja_640_22","article-title":"COVID-19 associated Mucormycosis (CAM): implications for perioperative physicians\u2013A narrative review","volume":"17","author":"Gupta","year":"2023","journal-title":"Saudi J Anaesth"},{"key":"2025112007565563500_ofaf674-B28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/jof5030059","article-title":"Mucormycosis of the central nervous system","volume":"5","author":"Chikley","year":"2019","journal-title":"J Fungi"},{"key":"2025112007565563500_ofaf674-B29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.acra.2021.12.007","article-title":"Post COVID-19 head and neck mucormycosis: MR imaging spectrum and staging","volume":"29","author":"Metwally","year":"2022","journal-title":"Acad Radiol"},{"key":"2025112007565563500_ofaf674-B30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11046-022-00670-5","article-title":"Risk factors of COVID-19 associated mucormycosis (CAM) in Iranian patients: a single-center retrospective study","volume":"187","author":"Tavakolpour","year":"2022","journal-title":"Mycopathologia"},{"key":"2025112007565563500_ofaf674-B31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1469-0691.2009.02974.x","article-title":"Clinical presentation of zygomycosis","volume":"15","author":"Mantadakis","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"2025112007565563500_ofaf674-B32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13760-012-0151-9","article-title":"Fatal rhinocerebral mucormycosis with intracavernous carotid aneurysm and thrombosis: a late complication of transsphenoidal surgery?","volume":"113","author":"Dusart","year":"2013","journal-title":"Acta Neurol Belg"},{"key":"2025112007565563500_ofaf674-B33","doi-asserted-by":"crossref","first-page":"e0272042","DOI":"10.1371\/journal.pone.0272042","article-title":"Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: case-control study, India","volume":"17","author":"Ponnaiah","year":"2022","journal-title":"PLoS One"},{"key":"2025112007565563500_ofaf674-B34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"haematologica"},{"key":"2025112007565563500_ofaf674-B35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11908-012-0272-6","article-title":"Rhino-orbital-cerebral mucormycosis","volume":"14","author":"Gamaletsou","year":"2012","journal-title":"Curr Infect Dis Rep"},{"key":"2025112007565563500_ofaf674-B36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B\u2013based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf674\/65099526\/ofaf674.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/11\/ofaf674\/65099526\/ofaf674.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/11\/ofaf674\/65099526\/ofaf674.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:57:11Z","timestamp":1763643431000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf674\/8313038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf674","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,10,30]]},"article-number":"ofaf674"}}